Colorimetric Method, Cpk Or Isoenzymes
Colorimetric Method for CPK or Isoenzymes is a clinical chemistry test system that employs colorimetric reactions to measure creatine kinase and its isoenzyme fractions in serum, supporting cardiac and muscular disease assessment. It is classified as FDA Class 2 (moderate risk), requiring 510(k) premarket notification and adherence to general and special controls. The product code is JHY, regulated under 21 CFR 862.1215, within the Clinical Chemistry medical specialty. This device is eligible for third-party 510(k) review.
Research product code JHY in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- JHY
- Device Class
- FDA class 2
- Regulation Number
- 862.1215
- Medical Specialty
- Clinical Chemistry
- Review Panel
- CH
- Submission Type
- 1
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 40 510(k) clearances via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K143720 | Dimension Vista MMB Assay | Sep 18, 2015 | Substantially Equivalent | Siemens Healthcare Diagnostics |
| K130080 | EASYRA CK-MB REAGENT, EASYRA CRP REAGENT, EASY CAL CRP CALIBRATOR KIT, EASYQC CRP QUALITY CONTROL MATERIAL | May 13, 2014 | Substantially Equivalent | Medica Corporation |
| K140404 | ELECSYS CK-MB STAT IMMUNOASSAY | May 08, 2014 | Substantially Equivalent | Roche Diagnostics |
| K132571 | ELECSYS CK-MB STAT IMMUNOASSAY, ELECSYS CK-MB IMMUNOASSAY | Oct 18, 2013 | Substantially Equivalent | Roche Diagnostics |
| K070835 | OLYMPUS CK-MB REAGENT | Jun 04, 2007 | Substantially Equivalent | Olympus Life & Material Science Europa GmbH (Irish |
| K022757 | SPIFE CK KIT, MODEL 3332, 3333 | Oct 11, 2002 | Substantially Equivalent | Helena Laboratories |
| K022654 | MODIFICATION TO ELECSYS CK-MB STAT, ELECSYS CK-MB | Aug 29, 2002 | Substantially Equivalent | Roche Diagnostics Corp. |
| K974421 | ELECSYS CK-MB STAT | Dec 17, 1997 | Substantially Equivalent | Boehringer Mannheim Corp. |
| K970343 | MMB METHOD | Feb 14, 1997 | Substantially Equivalent | Dade Chemistry Systems, Inc. |
| K961412 | CK-MB METHOD FOR THE TECHNICON IMMUNO 1 SYSTEM IN-VITRO | Jun 18, 1996 | Substantially Equivalent | Bayer Corp. |
| K951638 | AURAFLEX CK-MB 200TEST PACK, CALIBRATOR PACK | May 02, 1995 | Substantially Equivalent | Organon Teknika Corp. |
| K931172 | IMX(R) STAT CK-MB | Jun 15, 1993 | Substantially Equivalent | Abbott Laboratories |
| K924429 | OPUS(R) CK-MB | Oct 15, 1992 | Substantially Equivalent | Pb Diagnostic Systems, Inc. |
| K922700 | DU PONT ACA PLUS IMMUNOASSAY SYSTEM MB MCKMB METH. | Aug 20, 1992 | Substantially Equivalent | E.I. Dupont DE Nemours & Co., Inc. |
| K921763 | TANDEM ICON QSR CKMB IMMUNOENZYMETRIC ASSAY | Jun 09, 1992 | Substantially Equivalent | Hybritech, Inc. |
| K912766 | AMERLITE CK-MB ASSAY | Jul 17, 1991 | Substantially Equivalent | Amersham Corp. |
| K896240 | COBAS READY CK REAGENT | Feb 16, 1990 | Substantially Equivalent | Roche Diagnostic Systems, Inc. |
| K895870 | ISOSCREEN-CK CONFIRMATORY KIT | Dec 01, 1989 | Substantially Equivalent | Roche Diagnostic Systems, Inc. |
| K890295 | TARGET(TM) CK-MB | Aug 15, 1989 | Substantially Equivalent | V-Tech, Inc. |
| K884550 | CREATINE KINASE MB ENZYME IMMUNOASSAY KIT | Feb 23, 1989 | Substantially Equivalent | Bd Becton Dickinson Vacutainer Systems Preanalytic |
| K884085 | TANDEM ICON QSR CKMB IMMUNOENZYMETRIC ASSAY | Dec 02, 1988 | Substantially Equivalent | Hybritech, Inc. |
| K883013 | IMX CKMB | Aug 08, 1988 | Substantially Equivalent | Abbott Laboratories |
| K881351 | IMACK-MB, CATALOGS 602-1, 602-1/125, 602-1/225 | Jun 01, 1988 | Substantially Equivalent | Intl. Immunoassay Laboratories, Inc. |
| K875192 | KODAK EKTACHEM DT SLIDES (CKMB) | Feb 24, 1988 | Substantially Equivalent | Eastman Kodak Company |
| K880178 | CREATINE KINASE (COLORIMETRIC METHOD) | Feb 18, 1988 | Substantially Equivalent | Tech-Co, Inc. |
| K874545 | IMACK-MB TEST PROCEDURE (MODIFICATION) | Dec 18, 1987 | Substantially Equivalent | Intl. Immunoassay Laboratories, Inc. |
| K872063 | TANDEM-E IMMUNOENZYMETRIC ASSAY FOR CKMB II | Jun 19, 1987 | Substantially Equivalent | Hybritech, Inc. |
| K871677 | CREATINE KINASE FOR CONTINUOUS FLOW INSTRUMENTS | May 12, 1987 | Substantially Equivalent | Catachem, Inc. |
| K860663 | AMRESCO FLOW PAC CREATINE PHOSPHOKINASE REAGENT | Apr 11, 1986 | Substantially Equivalent | Amresco, Inc. |
| K845024 | BAKER CKMB REAGENT SET | Jan 18, 1985 | Substantially Equivalent | Hybritech, Inc. |
| K832977 | FLOW-PAC CPK REAGENT SET | Apr 05, 1984 | Substantially Equivalent | American Research Products Co. |
| K832139 | TANDEM - E-CKMB IMMUNOENZYMETRIC ASSAY | Aug 12, 1983 | Substantially Equivalent | Hybritech, Inc. |
| K832004 | WAKO CPK TEST | Aug 11, 1983 | Substantially Equivalent | Wako Chemicals USA, Inc. |
| K830672 | CREATINE KINASE REAGENT SET | Apr 05, 1983 | Substantially Equivalent | Sterling Biochemical, Inc. |
| K820812 | CREATINE KINASE-MB KIT | Apr 12, 1982 | Substantially Equivalent | Calbiochem-Behring Corp. |
| K800684 | REAGENT FOR DETERM. CREATINE PHOSPHOKINA | May 28, 1980 | Substantially Equivalent | Diagnostic Solutions, Inc. |
| K791655 | CPK ISOENZYME REAGENT | Sep 17, 1979 | Substantially Equivalent | Electrophoresis Corp. of America |
| K790309 | CPK ISOENZYME SUBSTRATE | Apr 04, 1979 | Substantially Equivalent | Electrophoresis Corp. |
| K761212 | CPK1SOENZYMES DETERMINATION PRO. #715-EP | Dec 21, 1976 | Substantially Equivalent | Sigma Chemical Co. |
| K760871 | LANCER MB/CPK ISOENZYME KIT | Nov 02, 1976 | Substantially Equivalent | Sherwood Medical Industries |
FEI Numbers
This FDA classification entry is associated with 11 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 11 registration numbers. Click on an entry to view related FDA registrations.